Articles about 'Cambridge Enterprise'

Professor Steve Jackson talks about drug discovery, serial entrepreneurship and the enterprising mindset.

The investment will accelerate the development of AI technology start-up Carbon Re to help the global cement industry and other energy-intensive industries reach net zero targets.

A team of engineers and clinicians has developed an ultra-thin, inflatable device that can be used to treat the most severe forms of pain without the need for invasive surgery.

Pioneering collaboration initiated by the University of Cambridge, Imperial College London and University College London

Researchers have created a plant-based, sustainable, scalable material that could replace single-use plastics in many consumer products.

The University of Cambridge announces the appointment of Dr Diarmuid O’Brien as the new Chief Executive of Cambridge Enterprise, effective September 2021.

Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published today in Nature, Cambridge researchers report a new approach to cancer treatment that targets enzymes which play a key role in translating DNA into proteins and which could lead to a new class of cancer drugs.

The vital role of ventilation in the spread of COVID-19 has been quantified by researchers, who have found that in poorly-ventilated spaces, the virus can spread further than two metres in seconds, and is far more likely to spread through prolonged talking than through coughing.

An award-winning team from Cambridge, Botswana, Mozambique and Namibia has been bolstering entrepreneurship in Southern Africa and supporting some exciting new ventures along the way.

A Cambridge-developed vaccine candidate against SARS-CoV-2 could begin clinical trials in the UK in late autumn or early next year, thanks to a £1.9million award from the UK government.